January 14, 2021 by Chain Drug Review
Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott, The Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) today issued 21 policy solutions supported by America’s pharmacy benefit managers (PBMs) aimed at reducing prescription drug costs for patients and health plan sponsors. PBMs administer prescription drug plans for more than 266 million Americans with health coverage through employers, health insurers, labor unions, Medicare and Medicaid. PBMs are the
January 12, 2021 by Chain Drug Review
Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott, The Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) today filed a lawsuit challenging the Trump Administration’s rebate rule. PCMA’s lawsuit, filed in the district court for the District of Columbia, asks the court to set aside the rebate rule under the Administrative Procedure Act. The PCMA lawsuit also includes a request for a declaration from the
December 3, 2020 by Chain Drug Review
Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott, The Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is announcing the addition of Michael Power as senior director, State Affairs and new roles for Tim Dube, Melodie Shrader, Heather Cascone, and Randy Kane. Michael Power joins PCMA with a long list of association state advocacy work in the Southeastern U.S. He brings experience and many
November 20, 2020 by Chain Drug Review
PCMA, Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott
Leading Headlines, Pharmacy
WASHINGTON— Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the Administration and Health and Human Services (HHS) Secretary Alex Azar finalizing the rebate rule (Removal of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection): “Simply put, the HHS Secretary’s
November 16, 2020 by Chain Drug Review
How PBMs Reduce Insulin Cost, National Diabetes Month, Pharmaceutical Care Management Association (PCMA), Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott
Leading Headlines, Pharmacy
WASHINGTON — In recognition of National Diabetes Month, the Pharmaceutical Care Management Association (PCMA) is outlining how pharmacy benefit managers, PBMs, are working to lower insulin costs and creating programs to support people with diabetes and improve health outcomes. “PBMs have been able to moderate insulin costs for most people with insurance,” said PCMA president and CEO
October 6, 2020 by Chain Drug Review
NCPA, Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott
Leading Headlines, Pharmacy
WASHINGTON — Today, the Pharmaceutical Care Management Association (PCMA), the national association representing pharmacy benefit managers (PBMs), fought to protect access to affordable, quality prescription drug coverage in front of the United States Supreme Court in oral arguments for Rutledge v. Pharmaceutical Care Management Association (PCMA). Argued by former Solicitor General Seth Waxman, PCMA’s case
September 8, 2020 by Chain Drug Review
Medicare, Alex Brill of Matrix Global Advisors (MGA), PCMA, Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott
Leading Headlines, Pharmacy
WASHINGTON — A new report, “Negative Economic Impact of Restricting Rebates in Medicare Part D,” by Alex Brill of Matrix Global Advisors (MGA), examines recent evidence showing that prescription drug rebates negotiated by pharmacy benefit managers (PBMs) reduce drug costs and lower premiums in Medicare Part D. The paper concludes that proposed government action to
August 17, 2020 by Chain Drug Review
Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott, Visante analysis
Leading Headlines, Pharmacy
WASHINGTON — A highly consolidated insulin market limits competition and allows dramatic price increases on new and existing brand-name products, according to a new Visante analysis: “Insulins: Managing Costs with Increasing Manufacturer Prices.” The Visante analysis finds that insulin list prices escalated over the past 5-10 years largely due to limited competition caused by an
July 30, 2020 by Chain Drug Review
Pharmaceutical Care Management Association (PCMA), Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the Administration’s announcement on 2021 Medicare Part D premiums: “PCMA applauds the Administration for its work continuing the success of the Part D program. Today’s announcement shows that the 2021 and 2020 average basic premiums are the second
July 28, 2020 by Chain Drug Review
PCMA, Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott, President Trump’s Executive Order to revive the so-called rebate rule
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is announcing the launch of a TV and digital advertising campaign on President Trump’s Executive Order to revive the so-called rebate rule. The campaign warns policymakers and the public that the Administration’s plan will drastically increase Medicare premiums for America’s seniors and most vulnerable. Click here to view the
July 24, 2020 by Chain Drug Review
Administration’s Executive Order to resurrect the rebate rule, Pharmaceutical Care Management Association (PCMA), Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the Administration’s Executive Order to resurrect the rebate rule: “The Administration’s decision last year to withdraw a proposed regulation on prescription drug rebates was the right decision. Reviving a rebate reform proposal now does not address the underlying
May 26, 2020 by Chain Drug Review
Pharmaceutical Care Management Association (PCMA), Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued on Tuesday the following statement applauding the Administration’s initiative, announced today, to reduce insulin costs for Medicare enrollees: “We commend the Administration for allowing Part D plan sponsors to offer a new, voluntary Medicare Part D plan, starting in 2021, under which
September 16, 2019 by Chain Drug Review
Pharmaceutical Care Management Association (PCMA), Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott, prescription drug rebates in Medicare Part D
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued the following statement on the Health and Human Services Officer of Inspector General report (OIG) on prescription drug rebates in Medicare Part D. “Today’s OIG report further dispels the false narrative about PBM-negotiated rebates and confirms that rebates lead to lower prescription
